ClinicalTrials.Veeva

Menu

Phenylephrine Dose and Mode of Administration for Spinal Anesthesia Induced Hypotension

Wake Forest University (WFU) logo

Wake Forest University (WFU)

Status

Withdrawn

Conditions

Spinal Anesthetics Causing Adverse Effects in Therapeutic Use
Complications; Cesarean Section

Treatments

Drug: Phenylephrine

Study type

Interventional

Funder types

Other

Identifiers

NCT02101047
IRB 26872

Details and patient eligibility

About

Three different regimens of phenylephrine are being evaluated to see if one is superior over the other in the maintenance of cardiac output while keeping normotension and/or treating hypotension experienced when receiving spinal anesthesia for cesarean delivery.

Full description

Phenylephrine will be administered in one of 3 regimens: Intermittent bolus of 50 mcg, Intermittent bolus of 100 mcg, or continuous infusion of 100 mcg/min. The infusion will contain either phenylephrine or normal saline (placebo). Subjects who are randomized to receive a bolus dose will receive placebo in the infusion. Subjects who are randomized to receive the phenylephrine infusion will have normal saline (placebo) in the bolus syringe. Baseline blood pressures will be obtained prior to surgery and then maintained using these drugs. Blood pressure and heart rate will be monitored as usual standard of care. Continuous cardiac output and hemodynamic monitoring will be obtained using CNAP (Tm) or similar (equivalent) monitoring device. Blood pressure will be maintained at 90-120% of baseline utilizing infusion and/or bolus with the 3 regimens.

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • scheduled for cesarean delivery age >/=18 years of age >/= 37 weeks EGA ASA status I-III

Exclusion criteria

  • allergy to medications used in the study non-English speaking

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

0 participants in 3 patient groups

phenylephrine 50mcg bolus
Experimental group
Description:
Phenylephrine 50 mcg bolus dosing with continuous placebo infusion
Treatment:
Drug: Phenylephrine
Phenylephrine 100 mcg bolus
Experimental group
Description:
Phenylephrine 100 mcg bolus dosing wtih continuous placebo infusion.
Treatment:
Drug: Phenylephrine
Phenylephrine continuous infusion 100mcg/min
Experimental group
Description:
Continuous phenylephrine infusion of 100 mcg/min with placebo bolus dosing.
Treatment:
Drug: Phenylephrine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems